Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT01580761
Insufficient sleep may be one of the most common, and most preventable, obesity risk factors. The investigators wish to determine whether 14 nights of modest sleep restriction results in increased energy balance, thus potentially increasing the risk of obesity. The investigators hypothesize that sleep restriction will result in increased energy balance.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
Numerous studies have reported that self-reported short sleep duration is associated with obesity and weight gain. Insufficient sleep may be one of the most common, and most preventable, obesity risk factors. Given that sleep restriction is largely voluntary and potentially correctable, understanding the mechanisms that link insufficient sleep to positive energy balance and the development of obesity, particularly visceral obesity, is crucial to clinical applications, public health policy, and informing future studies. The investigators wish to determine whether 14 nights of modest sleep restriction results in increased energy balance, thus potentially increasing the risk of obesity. The investigators will combine energy balance, biomarker, and imaging data with state-of-the art sleep monitoring to provide unambiguous data on the effects of sleep restriction on obesity. Together, the investigators findings will help explain whether the reduced sleep duration in the general population may be contributing to the current epidemic of obesity, and suggest strategies to reduce this risk.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
14 days of sleep restriction, 4 hours of sleep per day.
Time frame: baseline to 21 days
Change in caloric intake and hunger, measured during acclimation, experimental and recovery timepoints.
Time frame: baseline to 21 days
Change in energy expenditure, including activity energy expenditure, thermic effect of food (TEF), and basal metabolic rate (BMR), measured during acclimation, experimental and recovery timepoints..
Time frame: baseline to 21 days
Changes in fat tissue characteristics from serial fat biopsies, and in body composition from DEXA and CT imaging, measured during acclimation, experimental and recovery timepoints.
Time frame: baseline to 21 days
Change in metabolic hormones measured during acclimation, experimental and recovery timepoints.
Time frame: baseline to 21 days
Change in neurocognitive function measured by battery, measured during acclimation, experimental and recovery timepoints..
Time frame: baseline to 21 days
Change in mean arterial blood pressure and autonomic function, measured during acclimation, experimental and recovery timepoints.
Time frame: baseline to 21 days
Change in markers of inflammation and endothelial function, measured during acclimation, experimental and recovery timepoints.
Time frame: baseline to 21 days
Change in electrocardiographic characteristics, measured during acclimation, experimental and recovery timepoints.
Time frame: baseline to 21 days
Change in arterial stiffness, measured during acclimation, experimental, and recovery timepoints.
Time frame: baseline to 21 days
Change in cardiovascular reactivity, measured during acclimation, experimental, and recovery timepoints.
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05742165
Behavior, Body Weight
New York, United States
View Trial DetailsNCT05882045
Body Weight, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial DetailsNCT00342732
Body Weight, Nutrition Disorders
Phoenix, Arizona, United States
View Trial Details